173
Participants
Start Date
June 30, 2015
Primary Completion Date
February 29, 2020
Study Completion Date
February 29, 2020
Cyrcadia CBR™ device placement for abnormality screening
Cyrcadia CBR™ device, including adhesive patches on both breasts connected to a small recorder, is placed on the study subject for 2 to 24 hours. After the test period, the CBR™ will be removed and the data will be downloaded to a central site for analysis. There are no interventions after the CBR™ is removed from the Study Subject.
ACTIVE_NOT_RECRUITING
The Ohio State University, Stephanie Spielman Comprehensive Cancer Center, Columbus
RECRUITING
El Camino Hospital, Mountain View
Lead Sponsor
Stanford University
OTHER
Salesforce
UNKNOWN
Ohio State University
OTHER
Cyrcadia Health
INDUSTRY